News
Moderna's appetite for antibody tech spurs $6M bet on Nona's heavy chain only platform By Nick Paul Taylor Nov 11, 2022 7:30am Moderna Harbour BioMed antibody messenger RNA ...
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNano™. RenNano ...
BEIJING, June 05, 2025--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback